Tech Company Financing Transactions
Secretome Therapeutics Funding Round
On 5/28/2026, Secretome Therapeutics received $30 million in Series A financing from RA Capital and private investors.
Transaction Overview
Company Name
Announced On
5/28/2026
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
RA Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support its operations and the continued development of its pipeline.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
323 W. Camden Street 600
Baltimore, MD 21201
USA
Baltimore, MD 21201
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
At Secretome Therapeutics, we aim to redefine treatment for life-threatening diseases by leveraging the power of neonatal cardiac progenitor cells (nCPCs). Our mission is to improve lives through innovative science, scalable solutions, and targeted therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vinny Jindal
Browse more venture capital transactions:
Prev: 5/28/2026: Triomics venture capital transaction
Next: 5/28/2026: UtiliData venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs